Reddys

Markets extend losses for fourth day; pharma stocks buck trend

Dr Reddy's, Bajaj Auto, Sun Pharma, Asian Paints, Maruti and NTPC were among the gainers, climbing up to 2.56 per cent.

published on : 1st July 2021

Dr Reddy’s launches 2-DG to treat Covid

DR Reddy’s Laboratories announced the commercial launch of 2-deoxy-D-glucose (2-DG) drug for Covid-19 on Monday.

published on : 29th June 2021

Dr Reddy's initiates legal action against fraudulent entities offering Sputnik V vaccine

Dr Reddy's has fully put in place cold storage logistics as well as track-and-trace arrangements for the vaccine.

published on : 28th May 2021

Dr Reddy's Laboratories lines up Rs 1,000 crore capex for current fiscal

Dr Reddy's Laboratories CEO Erez Israeli noted that it depends on the COVID-situation that how much the company would be able to put in during the fiscal.

published on : 24th May 2021

Dr Reddy's in talks with RDIF on Sputnik V for other countries

Dr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for piloting the vaccine.

published on : 19th May 2021

1.5 lakh doses of Sputnik V arrives in India, likely to be incorporated in vaccination drive in few days

Dr Reddys has already received approval from Indian drug regulator for restricted emergency use of Sputnik V.

published on : 1st May 2021